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Summary The aim of the present study was to investigate whether the pneumonia
severity index (PSI) could adequately predict the severity of community-acquired
pneumonia (CAP) and could be used as a severity of illness classification system.
Furthermore, reasons that may influence the decision to admit low risk patients
were analysed.
In a prospective study 260 patients with CAP were included. Stratification in five
risk classes according to the PSI was compared with parameters that are closely
related to severity of CAP.
A significant difference in severity parameters, such as length of stay (Po0.001)
and simplified acute physiologic score and acute physiologic and chronic health
evaluation II score (Po0.001) was found between the five risk classes. Furthermore,
a positive British Thoracic Society (BTS) rule and modified BTS rule score was
significantly more prevalent in the higher risk classes (Po0.001). The patient
population had an average 30-day mortality of 10% and a mean Intensive Care Unit
(ICU) admission rate of 8%. The mortality rate and ICU admission rate significantly
differed between the five risk classes (Po0.001), in which the highest ICU admission
rate (40.9%) and the highest mortality percentage (40.9%) were both found in risk
class V.
Several clinical factors (n¼ 64), such as an exacerbation of chronic obstructive
pulmonary disease in 17 patients and clinical appearance of being ill in 16 patients,
lack of improvement on outpatient antibiotic therapy (n¼ 15) and social
circumstances (n¼ 3) were reasons that influenced the decision to hospitalise low
risk patients (n¼ 82).
The results show that the PSI adequately predicted the severity of CAP and can be
used as a severity of illness classification in CAP. Clinical and social factors other than
ARTICLE IN PRESS
KEYWORDS
PSI;
Risk classes;
Community-acquired pneu-
monia;
Severity assessment;
Hospital admission decision
$Part of this work was presented at the 97th International Conference of the American Thoracic Society, San Francisco, USA, on May
23, 2001; and at the 10th Annual Congress of the European Respiratory Society in Florence, Italy, on September 3, 2001.
*Corresponding author. Tel: þ 31-72-548-44-44; fax: þ 31-72-548-21-67.
E-mail address: w.boersma@mca.nl (W.G. Boersma).
0954-6111/$ - see front matter & 2004 Elsevier Ltd. All rights reserved.
doi:10.1016/j.rmed.2004.02.022
Respiratory Medicine (2004) 98, 872–878
those mentioned in the PSI have to be considered when making the decision to
hospitalise patients with CAP.
& 2004 Elsevier Ltd. All rights reserved.
Introduction
Most patients with community-acquired pneumonia
(CAP) are treated as outpatients, but many low risk
patients who could actually be treated at home are
still hospitalised. The reason arises from the
tendency of physicians to overestimate the risk of
complications in CAP.1 In 1997 Fine et al.2 devel-
oped a pneumonia severity index (PSI) by which low
risk patients with CAP can be identified. The reason
for developing such a PSI was to enable the
physician to make an objective assessment of the
risk of mortality and to improve the decision about
hospitalisation.
The PSI stratifies patients with CAP according to a
two-step model, based on variables as age, sex,
comorbid illness, vital sign abnormalities, and some
laboratory and radiographic abnormalities, into five
risk classes. Patients stratified in classes I and II
have a low risk of mortality and can be safely
treated at home. The PSI can be used as a tool
additional to the clinical judgement of the physi-
cian. An important consequence of applying the PSI
is a reduction in financial costs, using outpatient
treatment in low risk patients with CAP, thereby
resulting in a reduction of hospital admissions.
As a risk classification system the PSI has the
potential, apart from identifying low risk patients,
to be used as a tool in which processes of care and
the outcome of different management strategies
could be evaluated and compared with other
studies. It was decided to assess prospectively
whether the PSI could adequately stratify patients
in the different risk classes when evaluating the
severity of CAP in our health care system, and could
therefore serve as a severity of illness classification
system. Furthermore, reasons that may influence
the decision to admit low risk patients (risk classes I
and II) were analysed.
Methods
This prospective observational study was per-
formed in the Departments of Pulmonary Diseases
and Internal Medicine at the Medical Centre
Alkmaar, a teaching hospital with 900 beds.
Between December 1998 and November 2000, 303
hospitalised patients were included. As it is
common in our health care system, the majority
of patients first consult their general practitioner
(GP), and from this population a selected group was
referred to our hospital. Forty-three patients were
initially misdiagnosed and were subsequently ex-
cluded from the study. The results from 260
patients could be evaluated.
Patients who fulfilled the following inclusion
criteria for CAP were enrolled in the study after
giving written informed consent: (1) age of at least
18 years old; (2) clinical presentation of an acute
illness with two or more of the following symptoms
suggesting CAP: presence of fever, dyspnoea,
coughing (with or without expectoration of spu-
tum), chest pain; (3) presence of a new consolida-
tion on the chest radiograph. Patients were
excluded from the study if one of the following
criteria applied: presence of severe immunosup-
pression (HIV infection; high dose of immunosup-
pressive agents, like prednisone 435mg/day;
chemotherapy); presence of malignancy; preg-
nancy or breastfeeding; documented severe allergy
for antibiotics; presence of obstruction pneumonia;
CAP presenting within 8 days after hospital dis-
charge.
Patients were stratified into the five risk classes
of the PSI according to the classification of Fine
et al.2 The primary aim of this study was to assess
whether the PSI could adequately predict severity
of CAP and was therefore compared with length of
hospital stay (LOS), duration of intravenous anti-
biotic treatment (ABiv), total duration of antibiotic
therapy (ABtot), intensive care unit admission
(ICU), 30-day mortality, simplified acute physiolo-
gic score (SAPS),3 acute physiologic and chronic
health evaluation (APACHE) II score,4 positive
British Thoracic Society (BTS) rule,5 positive mod-
ified British Thoracic Society (mBTS) rule6 and the
results of the pneumonia patient outcomes re-
search team (PORT) prospective cohort study.2
Reasons that influenced the decision to hospita-
lise patients stratified in classes I and II were
analysed. These reasons were based on the
personal judgement of the physician about
the clinical or social situation of the patient at
the moment of admission. The treating physician
was not aware of the PSI risk class stratification.
All data necessary for calculating the PSI 2 were
prospectively collected at admission at day 1 by the
investigator (MMvdE). SAPS score, APACHE II score,
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BTS and mBTS score were calculated within 24 h
after admission. Data concerning LOS, ABiv, ABtot,
ICU admission and 30-day mortality were obtained
during hospitalisation and at 30-day follow-up.
Information concerning the cause of 30-day mor-
tality after discharge was obtained from the GP.
The investigator was not involved in the decision-
making process conducted by the treating physi-
cian, with respect to duration of antibiotic therapy
and the decision of hospital discharge. No criteria
for discharge were given to the treating physician.
These data were recorded in a SPSS 11.5 (Chicago,
USA) spreadsheet for Windows (Microsoft, USA).
Statistical analysis
Data were compared and analysed with one-way
analysis of variance (ANOVA) with post hoc Bonfer-
roni correction for continuous variables and with w2
test for nominal data using SPSS Version 11.5. Data
are expressed as means with standard deviation or
as absolute number. A result of Po0.05 was
considered to be significant.
Results
Demographic data from the 260 patients included
in the study are presented in Table 1. The mean age
was 64 years; 200 patients (77%) were aged450
years. The male and female populations were
almost equally distributed (54% versus 46%, respec-
tively). Only 6 patients (2%) were admitted from
nursing homes. The most common co-morbidity was
chronic obstructive pulmonary disease (COPD),
present in 103 patients (40%), followed by diabetes
mellitus (10%), asthma (9%), and congestive heart
failure (8%).
Table 2 details the assignment of patients into
the five risk classes. Ninety-two patients (35%) with
CAP were assigned to class IV, followed by 64
patients (25%) stratified in class III and 59 patients
(23%) in class II. Patients assigned to a lower risk
class were generally younger than patients classi-
fied in a higher risk class.
A significant difference in LOS was seen between
the five different risk classes (Po0.001). Patients
stratified in class V remained in the hospital for the
longest period, with a mean stay of 19.9 days. A
difference between the risk classes was also seen in
duration of ABiv (P¼ 0.007), while no significant
difference was found in length of ABtot (P¼ 0.14).
The PSI was compared with APACHE II score and
SAPS score. The scores obtained from these two
general predicting scoring systems increased sig-
nificantly with the stratification in the five risk
classes (Po0.001) (Table 3). However, no signifi-
cant difference in APACHE II and SAPS score was
seen between risk classes IV and V.
A positive BTS and mBTS score was significantly
more prevalent in the higher risk classes. In
contrast to the APACHE II and SAPS score, a
significant difference in positive BTS and positive
mBTS score was present between patients stratified
into risk class IV or V (Po0.001).
The patient population had an average 30-day
mortality of 10% and a mean ICU admission rate of
8%. The highest ICU admission rate (40.9%) and the
highest mortality percentage (40.9%) were both
found in risk class V. The mortality rate and ICU
admission rate significantly differed between the
five risk classes (Po0.001). Regarding the predic-
tion of mortality in the present study population,
stratification in risk class V showed a sensitivity of
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Table 1 Demographic characteristics of the study
population (n¼ 260).
Variables Number (%)
Mean age, years (7SEM) 64 (1.1)
p50 years 60 (23%)
450 years 200 (77%)
Sex
Male 140 (54%)
Female 120 (46%)
Nursing home residents 6 (2%)
Comorbidity
Chronic obstructive
Pulmonary disease 103 (40%)
Asthma 23 (9%)
Congestive heart failure 20 (8%)
Ischemic heart disease 17 (7%)
Cerebrovascular accident 4 (2%)
Other neurologic disorder 20 (8%)
Liver disease 2 (1%)
Renal disease 2 (1%)
Diabetes mellitus 25 (10%)
Smoking
Smoker (X10 cigarettes/day) 74 (28%)
Smoker (o10 cigarettes/day) 9 (3%)
Ex-smoker 79 (30%)
Non-smoker 87 (33%)
Alcohol
Drinker (43 units/day) 12 (5%)
Non-drinker 232 (89%)
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33%, a specificity of 94%, a positive predictive value
of 41% and a negative predictive value of 92% (data
not shown).
Table 4 shows the reasons for admission of the 23
patients (9%) of class I and of the 59 patients (23%)
of class II. The reasons for admission (in order of
prevalence) were: acute chest pain in 30 patients
(37%) (in most cases the presence of a suspected
pulmonary embolism needed to be excluded); an
exacerbation of COPD in 17 patients (21%); clinical
appearance of being ill in 16 patients (20%); no
improvement on oral outpatient antibiotic therapy
in 15 patients (18%) and hypoxemia in 1 patient
(1%). Three patients (4%) could have been treated
at home, but preferred treatment in a hospital for
social reasons.
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Table 2 Comparison of the five risk classes of the pneumonia severity index concerning age, length of hospital
stay and duration of antibiotic treatment.
Risk class I (n¼ 23) II (n¼ 59) III (n¼ 64) IV (n¼ 92) V (n¼ 22) Overall* (n¼ 260) P-value**
Age, years (range) 38.6 (30-50) 49.0 (19-78) 68.3 (26-90) 74.0 (34-97) 78.2 (51-91) 64.1 (19-97) o0.001
LOS, days (SD) 7.4 (3.9) 10.0 (6.3) 12.7 (9.9) 15.8 (11.5) 19.9 (22.3) 13.3 (11.5) o0.001
ABiv, days (SD) 3.6 (2.5) 4.8 (2.9) 4.5 (2.0) 6.3 (5.3) 6.2 (5.2) 5.3 (4.1) 0.007
ABtot, days (SD) 9.7 (2.6) 11.0 (6.9) 9.6 (3.5) 11.1 (5.5) 8.6 (5.5) 10.4 (5.3) 0.14
LOS ¼ length of stay; ABiv ¼ duration of intravenous antibiotic use; ABtot ¼ total duration of antibiotic therapy.
*All results are expressed as mean values with standard deviation (SD), with exception of age (range).
**P-values calculated with one-way analysis of variance (ANOVA) for comparison of the risk classes.
Table 3 Severity assessment in the five risk classes of the pneumonia severity index.
Risk class I (n¼ 23) II (n¼ 59) III (n¼ 64) IV (n¼ 92) V (n¼ 22) Overall* (n¼ 260) P-value**
SAPS 3.1 5.7 7.7 10.2 12.1 8.1 o0.001
APACHE II 5.0 8.9 12.2 15.8 18.1 12.2 o0.001
BTS, n (%) 0 3 (5) 7 (11) 29 (32) 19 (86)*** 58 (22) o0.001
mBTS, n (%) 0 4 (7) 9 (14) 41 (45) 22 (100)*** 76 (29) o0.001
ICU, n (%) 0 2 (3.4) 1 (1.6) 10 (11) 9 (40.9) 22 (8) o0.001
Mortality, n (%) 0 1 (1.7) 3 (4.7) 14 (15.2) 9 (40.9) 27 (10) o0.001
PORT ICU % 4.3 4.3 5.9 11.4 17.3 9.2 o0.001
PORT mortality % 0.1 0.6 0.9 9.3 27 5.2
SAPS¼ simplified acute physiologic score; APACHE¼ acute physiologic and chronic health evaluation; BTS¼British thoracic
society rule; mBTS¼modified British thoracic society rule; ICU¼ intensive care unit; PORT¼pneumonia patient outcomes
research team study.
*All results are expressed in absolute numbers, with the exception of SAPS and APACHE score, which are expressed as mean
values.
**P-values for comparison of the risk classes calculated with one-way analysis of variance (ANOVA) for SAPS and APACHE score
and w2 test calculation for BTS, mBTS, ICU and mortality.
***Po0.001 compared to risk class IV, after w2 test calculation.
Table 4 Reasons for hospital admission of patients stratified in classes I and II.
Reasons for admission Class I (n¼ 23) Class II (n¼ 59) Overall (n¼ 82)
Acute chest pain, n (%) 12 (52) 18 (30) 30 (37)
Exacerbation COPD, n (%) 1 (4) 16 (27) 17 (21)
Clinical appearance of being ill, n (%) 4 (17) 12 (20) 16 (20)
Lack of improvement on oral antibiotic therapy, n (%) 6 (26) 9 (15) 15 (18)
Hypoxemia*, n (%) 0 1 (2) 1 (1)
Social circumstances, n (%) 0 3 (5) 3 (4)
COPD ¼ chronic obstructive pulmonary disease.
*PO2o60mm Hg.
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Age is a very important variable in the PSI.
According to the two-step model patients450
years can directly be placed in risk classes II–V.
Seven patients (3%) aged r50 years old were
hospitalised because of a clinical appearance of
being ill, although they did not score enough points
for stratification in a higher risk classes (class III–V).
Two of these patientsFbesides having clinical signs
of severe CAPFwere suspected of having meningi-
tis. With radiological imaging the diagnosis of lung
abscesses was confirmed in two patients, and a
prolonged course of intravenous antibiotics was
prescribed. At presentation three other patients
displayed a combination of symptoms, which made
hospitalisation necessary.
In some studies low risk patients are defined as
patients stratified in risk classes I to III.7–9 Three
patients (4.7%) stratified in risk class III died; two of
them had a Legionella pneumophila infection. In
the other patient no pathogen could be identified.
All three patients showed a positive mBTS score. In
risk class II one patient died because of the
presence of multi-organ failure caused by pneumo-
nia and confirmed meningitis.
Discussion
The present study showed that the PSI could
predict severity of CAP adequately. When predict-
ing mortality and ICU admission, the PSI adequately
stratified patients with CAP in the five different risk
classes. The highest ICU admission and mortality
rates were found in risk classes IV and V. This is in
accordance with the results of the PORT study2 and
the results published by Ewig et al.10 and Roson
et al.11 APACHE II, SAPS, positive BTS and mBTS
score showed increasing trends across all 5 risk
classes. No difference between the risk classes was
seen in the total duration of antibiotic use,
reflecting the general opinion of treating CAP with
a course of antibiotics during 7–10 days, irrespec-
tive of the severity of CAP.12 Acute chest pain,
exacerbation of chronic obstructive pulmonary
disease, clinical judgement overruling the PSI, lack
of improvement on oral outpatient antibiotic
therapy and social circumstances were reasons that
influenced the decision to hospitalise low risk
patients.
The PSI was originally developed to identify low
risk patients with CAP, based on risk of death within
30 days. Validation of the prediction rule was
performed with data from a database of 38,000
patients and with data from the PORT study.2 The
primary aim of our study was to determine whether
the PSI could also serve as a specific severity of
illness classification system for CAP. Therefore,
we validated the PSI with several other severity
outcome parameters besides risk of death.
We consider that the use of the PSI as a
severity of illness classification system is impor-
tant, because the composition of a study
population with CAP will become clearer. In
this way processes of care and outcomes in
management can be evaluated,13 furthermore
different studies of CAP can be compared
more precisely on their outcome. Our results
together with the results of the PORT study2 and
the results of the studies performed by Ewig et al.10
and Roson et al.11 suggest that the PSI can also be
used as a specific severity of illness classification
system for CAP. It can serve as a system to stratify
patients into classes of comparable severity by
analogy with the APACHE II and SAPS scoring
systems.
According to the PSI the decision to hospitalise a
patient with CAP is based only on the severity of
CAP. In the present study five reasons were found
that played an important role in the decision to
admit the 82 patients (32%) stratified in classes I
and II. These were: (a) acute chest pain; (b) the
presence of COPD; (c) lack of improvement on oral
outpatient antibiotic therapy; (d) clinical judge-
ment overruling the PSI; (e) social circumstances.
These factors are not mentioned in the PSI, but it is
important to consider them when making the
decision whether or not to hospitalise a patient
with CAP. For example, the presence of COPD as co-
morbidity in CAP is often considered to be an
important risk factor leading to admission and
mortality.1,6,7,11,12,14–18
Another reason for hospital admission in this
study was a lack of response to initial therapy
started by a GP. This is also mentioned as a hospital
admission criterion in a study performed by
Menendez et al.7 and by the European Study on
CAP Committee.19
An important point that should also be taken into
consideration when using the PSI is the variable of
age. In this scoring system age has a major
influence on risk class stratification, because of
the high amount of points assigned to it. In the
present study a number of young patients who had
the appearance of being very ill, and for whom
hospitalisation was necessary, were stratified in a
low risk class. The clinical judgement of the
treating physician in these cases overruled the
predictive value of the PSI. The major influence of
age in the PSI is also brought to attention in the
current guidelines of the American Thoracic
Society.20
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Marras et al.8 also investigated reasons for the
admission of low risk patients. Comorbid illness,
failure of outpatient antibiotic therapy and social
circumstances were mentioned as reasons for
hospitalisation. Although this was a retrospective
study these results were very similar to the
outcomes of this present prospective study. An-
other study9 assessed whether applying the PSI
could safely increase the proportion of low risk
patients treated at home. Of the 166 identified low
risk patients, only 94 (57%) were treated as
outpatients and 72 (43%) were admitted. In a later
study the reasons for admission of this patient
group were described (18). Predictors for hospital
admission, after multivariate analysis, were age
X65 years, multilobar pneumonia and the presence
of other comorbid conditions. Interestingly, the
physicians’ self-reported reasons for admission
were also described. The presence of other active
comorbidities and the clinical judgment that the
pneumonia was worse than the PSI score indicated
influenced the decision to hospitalise a low risk
patient. This observation underlines the fact that a
considerable percentage of patients has to be
admitted to the hospital for several reasons,
despite stratification in a lower risk class.
In the present study we did not analyse reasons
for admission of patients from risk class III. The
Infectious Diseases Society of America recommends
to treat patients from risk class III as outpatients or
to observe them for a brief period in the hospital.21
The results showed a mortality percentage of 4.7
(n¼ 3) in this patient category, compared to a
predicted mortalityo1% in the PORT study. Inter-
estingly all 3 patients had a positive mBTS score.
When interpreting the results one has to realise
that the Health Care system in the Netherlands is
different from other countries, like for example the
USA, which may influence the sort of study
population referred to the hospital. As is mentioned
in the methods section many patients in our
country initially visit the GP. When necessary, the
GP subsequently refers patients to the hospital.
The presence of comorbidity (50% in our study) and
the severity of disease are in this context impor-
tant. When making this decision, the GP does not
have the opportunity of obtaining the laboratory
values needed in the PSI. The decision to hospita-
lise is therefore based on clinical judgement.
However, there is clearly need for a simple tool to
make this decision more objective. This applies
especially to the first step of the PSI, in the form of
information about age, co-morbidity and abnormal
vital signs. But this information only is insufficient
for stratification in classes III, IV and V, which
require the availability of laboratory tests and a
chest X-ray. Under these circumstances the PSI does
not seem to be an adequate instrument for the GP
in the Netherlands to use. Whether the PSI should
be adapted for this situation could be an area for
future research.
In conclusion, the PSI adequately stratified
patients in the different risk classes according to
severity of CAP and therefore can be used as a
severity of illness classification for CAP. This has
important consequences for evaluating processes of
care and outcomes of therapy in patients with CAP.
The present study has also demonstrated that the
decision to hospitalise patients with CAP cannot be
based purely on the severity of CAP according to
the PSI. Various reasons could influence this
decision. In our opinion the variable of age counts
too heavily in the scoring of the PSI. As a
consequence some young patients with severe
CAP will not be stratified in a higher risk class,
which is necessary for being admitted. Further
research is needed to optimise an adequate tool for
the physician who has to make the difficult decision
about admitting patients with CAP.
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